Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate

Therapeutic Delivery

Volumn 1, Issue 1, 2010, Pages 75-82

  Wang, Xuexuan ^a   Maher, Sam ^a   Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DECANOATE SODIUM; DECANOIC ACID; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; COLON ABSORPTION; COLON INJURY; COLON MUCOSA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HISTOPATHOLOGY; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; REACTION OPTIMIZATION; TISSUE REPAIR; TISSUE STRUCTURE;

EID: 79955006040     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.10.5     Document Type: Article

References (34)

1. Maher S, Leonard TW, Jacobsen J, Brayden DJ. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. Adv. Drug Del. Rev. 61(15), 1427-1449 (2009).
2. Lindmark T, Soderholm JD, Olaison G, Alvan G, Ocklind G, Artursson P. Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm. Res. 14(7), 930-935 (1997). (Pubitemid 27326990)
3. Murakami T, Kawakita M, Kishimoto M et al. Intravenous and subcutaneous pharmacokinetics and rectal bioavailability of human epidermal growth factor in the presence of absorption promoter in rats. Int. J. Pharm. 46(1-2), 9-17 (1988).
4. Kamm W, Jonczyk A, Jung T, Luckenbach G, Raddatz P, Kissel T. Evaluation of absorption enhancement for a potent cyclopeptidic anb3-antagonist in a human intestinal cell line (Caco-2). Eur. J. Pharm. Sci. 10(3), 205-214 (2000). (Pubitemid 30190096)
5. Maher S, Kennelly R, Bzik VA et al. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae. Eur. J. Pharm. Sci. 38(4), 291-300 (2009).
6. Maher S, Wang X, Bzik V, McClean S, Brayden DJ. Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies. Eur. J. Pharm. Sci. 38(4), 301-311 (2009).
7. Hardee GE, Tillman LG, Geary RS. Routes and formulation for the delivery of antisense oligonucleotides. In:Antisense Drug Technology Principle, Strategies and Applications. Crooke ST (Ed.). CRC Press, FL, USA 217-236 (2008).
8. McHugh C, Madigan K, Walsh A, Fox J, Leonard TW, Quint JB. Mer-101, a multicenter, Phase II study to compare Mer-101 20 mg tablets to intravenous zoledronic acid 4 mg in prostate cancer patients. J. Clin. Oncol. 27(Suppl. 15), 5161 (2009).
9. Leonard TW, Lynch J, McKenna MJ, Brayden DJ. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET. Expert Opin. Drug Deliv. 3(5), 685-692 (2006). (Pubitemid 44383494)
10. Amory JK, Leonard TW, Page ST, O'Toole E, McKenna MJ, Bremner WJ. Oral administration of the GNRH antagonist acyline, in a GIPET®-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics. Cancer Chemother. Pharmacol. 64(3), 641-645 (2009).
11. Swenson SE, Curatolo WJ. (C) Means to enhance penetration: (2) intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Del. Rev. 8(1), 39-92 (1992).
12. Ward PD, Tippin TK, Thakker DR. Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm. Sci. Technol. Today 3(10), 346-358 (2000).
13. Coyne CB, Kelly MM, Boucher RC, Johnson LG. Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am. J. Respir. Cell Mol. Biol. 23(5), 602-609 (2000).
14. Sugita Y, Takao K, Toyama Y, Shirahata A. Enhancement of intestinal absorption of macromolecules by spermine in rats. Amino Acids 33(2), 253-260 (2007). (Pubitemid 47222978)
15. Morimoto Y, Mutoh M, Ueda H et al. Elucidation of the transport pathway in hairless rat skin enhanced by low-frequency sonophoresis based on the solute-water transport relationship and confocal microscopy. J. Control. Release 103(3), 587-597 (2005). (Pubitemid 40471017)
16. Raoof AA, Ramtoola Z, McKenna B, Yu RZ, Hardee G, Geary RS. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur. J. Pharm. Sci. 17(3), 131-138 (2002). (Pubitemid 35248266)
17. Takahashi K, Murakami T, Kamata A, Yumoto R, Higashi Y, Yata N. Pharmacokinetic analysis of the absorption enhancing action of decanoic acid and its derivatives in rats. Pharm. Res. 11(3), 388-392 (1994). (Pubitemid 24117357)
18. Takahashi K, Murakami T, Yumoto R, Hattori T, Higashi Y, Yata N. Decanoic acid induced enhancement of rectal absorption of hydrophilic compounds in rats. Pharm. Res. 11(10), 1401-1404 (1994). (Pubitemid 24339645)
19. Fix JA. Strategies for delivery of peptides utilizing absorption-enhancing agents. J. Pharm. Sci. 85(12), 1282-1285 (1996). (Pubitemid 27014180)
20. Schiller C, Frohlich CP, Giessmann T et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment. Pharmacol. Ther. 22(10), 971-979 (2005). (Pubitemid 41634879)
21. De Boer AG, Breimer D. GI-tract absorption enhancement: general introduction and simulation of time-concentration-effect profiles of absorption enhancers. In:Drug Absorption Enhancement Concepts, Possibilities, Limitations and Trends De Boer AG (Ed.). Harwood Academic Publishers, NJ, USA 155-175 (1994).
22. Van Hoogdalem E, De Boer AG, Breimer DD. Pharmacokinetics of rectal drug administration, I. General considerations and clinical applications of centrally acting drugs. Clin. Pharmacokinet. 21(1), 11-26 (1991).
23. Anderberg EK, Lindmark T, Artursson P. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. 10(6), 857-864 (1993). (Pubitemid 23167568)
24. Shima M, Kimura Y, Adachi S, Matsuno R. Recovery of Caco-2 cell monolayers to normal from the transport-enhanced state induced by capric acid sodium salt an its monoacylglycerol. Biosci. Biotechnol. Biochem. 63(4), 680-687 (1999). (Pubitemid 129549258)
25. Baluom M, Friedman M, Rubinstein A. The importance of intestinal residence time of absorption enhancer on drug absorption and implication on formulative considerations. Int. J. Pharm. 176(1), 21-30 (1998). (Pubitemid 28544968)
26. Narkar Y, Burnette R, Bleher R, Albrecht R, Kandela A, Robinson JR. Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer. Pharm. Res. 25(1), 25-38 (2008).
27. Nakanishi K, Masada M, Nadai T. Effect of pharmaceutical adjuvants on the rectal permeability of drugs. III. Effect of repeated administration and recovery of the permeability. Chem. Pharm. Bull. 31(11), 4161-4166 (1983). (Pubitemid 14208655)
28. Sekine M, Terashima H, Sasahara K, Nishimura K, Okada R, Awazu S. Improvement of bioavailability of poorly absorbed drugs. II. Effect of medium chain glyceride base on the intestinal absorption of cefmetazole sodium in rats and dogs. J. Pharmacobiodyn. 8(4), 286-295 (1985). (Pubitemid 15055787)
29. Raoof AA, Chiu P, Ramtoola Z et al. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. J. Pharm. Sci. 93(6), 1431-1439 (2004). (Pubitemid 38725017)
30. Tillman LG, Geary RS, Hardee GE. Oral delivery of antisense oligonucleotides in man. J. Pharm. Sci. 97(1), 225-236 (2008).
31. Ryan AJ, Chang RT, Gisolfi CV. Gastrointestinal permeability following aspirin intake and prolonged running. Med. Sci. Sport Exer. 28(6), 698-705 (1996). (Pubitemid 26184081)
32. Dastych M, Dastych M, Novotna H, Cihalova J. Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease. Dig. Dis. Sci. 53(10), 2789-2792 (2008).
33. Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: Efficacy, acute local toxicity, and reversibility. Pharm. Res. 11(8), 1132-1142 (1994). (Pubitemid 24259853)
34. Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol. Rev. 87(2), 545-564 (2007). (Pubitemid 47084680)